Artificial Labs raises £33m in funding round to grow globally

Artificial Labs has completed its $45m (£33m) series B funding round as it continues to expand its global market presence.

The latest round was led by European fintech investor CommerzVentures, with support from business to business technology investor Move Capital Fund I.

Artificial Labs will use the funds to expand its global footprint into the US in 2026, while growing its presence and consolidating its position in the London market.

David King, co‑founder of Artificial Labs, said: “This round gives us the room to grow with confidence.

“The investment allows us to scale in a way that keeps pace with our clients. We have the teams, the technology and the stability to support the largest brokers and carriers as they modernise how they operate.”

Johnny Bridges, fellow co‑founder of Artificial Labs, added: “We have built a platform that solves real problems for insurance.

“With this investment, we will grow our team, continue to innovate and ensure that Artificial Labs remains the natural choice for brokers and carriers seeking a smarter way to trade digitally.”

Continued Backing 

Alongside CommerzVentures and Move Capital Fund I, the round includes continued backing from Augmentum Fintech, Six Degrees Capital, FOM and TrueSight Ventures. 

Heiko Schwender, managing partner at CommerzVentures, said: “We are thrilled to support Artificial Labs as it extends its leadership globally.

“We have been backing next generation technology businesses for more than a decade. Artificial’s platform addresses a real, structural problem that has constrained efficiency in commercial and specialty insurance for decades. The team’s combination of deep insurance domain expertise and world class engineering is rare and it uniquely positions them to redefine this market.”

Hervé Malausséna, founding partner at Move Capital Fund I, added: “Artificial Labs benefits from a rare blend of deep insurance expertise, strong client relationships and highly innovative technology.

”The company is ideally positioned to address bottleneck challenges for specialty risk placement players globally, which reflects Move Capital’s conviction in platforms that turn domain expertise into scalable, data-driven operational execution.”